World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—
Cellmid Limited in brief
Cellmid Limited is a listed company in the Biotechnology industry, based in Australia. Its shares trade under the symbol CDY.AX (ASX).
Written from the figures on this page, so it changes when they do. The date of each figure is under How current the figures are.
Market cap history
Not enough history yet.
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Cellmid Limited🇦🇺 | — | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
How current the figures are
- Profile updated:
- Nov 4, 2026
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Cellmid Limited? Verify and update this profile — free
Show Cellmid Limited's ranking on your website Get the badge
The badge updates itself as the ranking changes.